Clinical Trial

Recovery From ICUAW Following Severe Respiratory and Cardiac Failure

Study acronym: CLEVERER
Recruiting
View on ClinicalTrials.gov →
Summary
To observe and identify determinants of recovery from intensive care unit-acquired weakness (ICUAW) following a severe cardiorespiratory failure requiring extra-corporeal membrane oxygenation (ECMO). Additionally, to discover the effects of ICUAW on physical function and health-related quality of life (HRQoL) after critical illness. CLEVERER is a clinical observational pilot study.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2018-11-22; most recent amendment 2026-01-05.
Status change: Active, Not Recruiting → Recruiting 2024-03-21
Status change: Recruiting → Active, Not Recruiting 2021-11-29
Status change: Not Yet Recruiting → Recruiting 2019-03-12
Trial Details
NCT Number NCT03753412
Lead Sponsor Barts & The London NHS Trust
Collaborators: Queen Mary University of London
Conditions Intensive Care Unit Syndrome, Intensive Care Neuropathy, Intensive Care (ICU) Myopathy, Acute Respiratory Distress Syndrome, Cardiac Failure, Respiratory Failure, Critical Illness Myopathy
Enrollment 100 participants
Start Date 2019-04-09
Primary Completion 2026-09-26 (estimated)
Study Completion 2026-09-26 (estimated)
Updated on ClinicalTrials.gov 2026-01-07